156951-82-5 Usage
Uses
Chrysotoxine, despite its concerning health effects, may have potential applications in various industries, although it is crucial to exercise caution and ensure safety in any use. The following are hypothetical applications based on the properties of Chrysotoxine:
Used in Research and Development:
Chrysotoxine is used as a research compound for studying its toxicological effects and potential applications in understanding the mechanisms of neurotoxicity and genotoxicity. This helps in developing methods to detect and mitigate its presence in food products.
Used in Food Safety and Quality Control:
Chrysotoxine is used as a biomarker in food safety and quality control processes to monitor and prevent contamination from fungi that produce this compound, ensuring the safety of food products for consumers.
Used in Pharmaceutical Development:
Although Chrysotoxine has toxic properties, it may be used in the development of pharmaceuticals as a starting point for creating compounds with targeted therapeutic effects, provided that the toxic effects can be mitigated or controlled.
Check Digit Verification of cas no
The CAS Registry Mumber 156951-82-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,9,5 and 1 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 156951-82:
(8*1)+(7*5)+(6*6)+(5*9)+(4*5)+(3*1)+(2*8)+(1*2)=165
165 % 10 = 5
So 156951-82-5 is a valid CAS Registry Number.
156951-82-5Relevant articles and documents
Synthesis and evaluation of neuroprotective 4-O-substituted chrysotoxine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease
Guan, Li,Hao, Yanfeng,Chen, Lei,Wei, Meng-Lin,Jiang, Qin,Liu, Wen-Yuan,Zhang, Yan-Bo,Zhang, Jie,Feng, Feng,Qu, Wei
, p. 22827 - 22838 (2016)
A series of 4-O-substituted chrysotoxine (CTX) derivatives were designed, synthesized and evaluated as multifunctional agents for the treatment of Alzheimer's disease (AD). In vitro assays indicated that four ring substituted compounds (2a, 2b, 3i and 3j)
